SYH2085

DRUG2 trials

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Conditions

Healthy ParticipantsInfluenza

Phase 1

A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085

RecruitingNCT07412353

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Healthy Participants

Start: 2026-01-12End: 2026-12-31Target: 74Updated: 2026-02-17

Phase 2

A Study of SYH2085 Tablets Compared With Placebo in Chinese Adult Patients With Uncomplicated Influenza.

Not yet recruitingNCT07798193

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Influenza

Start: 2026-10-10End: 2027-06-30Target: 213Updated: 2026-09-01